lymph node involvement

Related by string. * Lymph : cancerous lymph nodes . sentinel lymph node . enlarged lymph nodes . swollen lymph glands . lymph node metastases / Node . Nodes . NODE . nodes : var nodes = . swollen lymph nodes . mesh nodes . sentinel node biopsy / involvements . INVOLVEMENT . Involvement : flatly denies involvement . Denies Involvement . Community Involvement Coordinator . Parental Involvement * *

Related by context. All words. (Click for frequent words.) 78 lymph node metastases 76 distant metastases 74 lymph node metastasis 73 extracapsular extension 72 nodal metastasis 72 distant metastasis 72 nodal metastases 71 advanced adenomas 70 pT3 70 SLNB 69 locoregional recurrence 69 lymphadenectomy 69 biochemical recurrence 69 histologic 69 atypical hyperplasia 69 axillary nodes 69 prostate carcinoma 69 lymphovascular invasion 68 locoregional 68 seminal vesicle invasion 68 axillary lymph nodes 68 mucinous 68 postoperative chemotherapy 68 neoadjuvant therapy 68 pancreatic adenocarcinoma 68 advanced neoplasia 68 axillary dissection 67 pT2 67 micrometastases 67 node metastases 67 EUS FNA 67 operable breast cancer 67 adjuvant radiotherapy 67 radical nephrectomy 67 invasive carcinoma 67 axillary lymph node 67 resected 67 resectable 67 pCR 67 sentinel lymph node biopsy 67 axillary node 67 lung nodules 66 renal tumors 66 malignant lesions 66 mediastinal 66 preoperative PSA 66 histopathologic 66 liver metastasis 66 proximal colon 66 preoperative chemotherapy 66 lymph node removal 66 PSADT 66 tumor recurrence 66 neoadjuvant 66 sentinel nodes 66 tumor histology 66 carotid stenosis 66 lymph node dissection 66 gadolinium enhanced 66 HNSCC 66 underwent resection 66 T1a 66 breast carcinoma 65 Hurthle cell 65 advanced adenoma 65 intestinal metaplasia 65 colorectal neoplasms 65 adenoma 65 histologic subtype 65 HER2 expression 65 adrenalectomy 65 hormone receptor negative 65 echogenicity 65 urothelial carcinoma 65 neoadjuvant chemotherapy 65 micrometastasis 65 adjuvant radiation 65 renal cell carcinomas 65 poorer prognosis 65 T1c 65 completely resected 65 histologically confirmed 65 lobular carcinoma 65 HER2 negative 65 curative resection 65 nonmetastatic 65 histological subtype 65 metastases 65 stenoses 65 Lymph node 65 malignant neoplasm 65 CIN3 65 sonographically 65 PCa 65 EBRT 64 metastatic lesions 64 metastatic disease 64 sarcomatoid 64 perineural invasion 64 lymphadenopathy 64 neoplasms 64 biochemical relapse 64 para aortic 64 BRCA1 mutation carriers 64 medically inoperable 64 histopathological 64 SUVmax 64 HER2 positive tumors 64 radiochemotherapy 64 contralateral breast 64 lymph node 64 radical prostatectomy RP 64 adenomatous polyps 64 cytoreductive surgery 64 pelvic lymphadenectomy 64 EGFR mutation positive 64 endometrial carcinoma 64 FDG uptake 64 histologically 64 cystectomy 64 Preoperatively 64 radiographic findings 64 F FDG PET 64 neoplasm 64 peritoneal cancer 64 plain radiographs 64 univariate analysis 64 estrogen receptor ER 64 hematologic toxicity 64 epithelial tumors 64 gastric adenocarcinoma 64 wedge resection 64 ultrasonographic 64 Subgroup analyzes 63 hyperplastic polyps 63 clinically detectable 63 mammographically 63 polypoid lesions 63 Subgroup analysis 63 adjuvant chemotherapy 63 cervical lymph nodes 63 prostate cancer CaP 63 PSA nadir 63 EGFR mutations 63 hepatocellular carcinomas 63 metastatic RCC 63 #.#ng/ml 63 lymph nodes 63 breast lesions 63 pneumonectomy 63 nodal dissection 63 thyroid nodules 63 axillary node dissection 63 lobular carcinomas 63 IV NSCLC 63 histopathologic examination 63 malignant polyps 63 postoperative morbidity 63 microbleeds 63 CIN2 + 63 colorectal polyp 63 coronary calcification 63 nondiabetic patients 63 FDG PET 63 adjuvant therapy 63 postoperative radiotherapy 63 lymphocytosis 63 scintigraphic 63 nephrectomy 63 liver metastases 63 sonographic findings 63 postoperative complication 63 mediastinoscopy 63 K ras mutations 63 serum PSA 63 thyroid carcinoma 63 stage IIIB 63 renal carcinoma 63 occult metastases 63 MGUS 63 gastric carcinoma 63 conventional angiography 63 adnexal mass 63 mammographic density 63 Radical prostatectomy 63 neoplasias 63 systolic dysfunction 63 rebleeding 63 monoclonal gammopathy 63 oncologic outcomes 63 perioperative mortality 63 ALND 63 precancerous polyp 63 ischemic lesions 63 HER2 positive cancers 63 KRAS mutations 63 seminoma 63 preoperative diagnosis 63 papillary 62 sentinel node 62 radiotherapy RT 62 FDG-PET/CT 62 mediastinum 62 carcinoma 62 adnexal masses 62 ovarian carcinoma 62 hamartomas 62 multivariate analyzes 62 NNRTI resistance 62 lung metastases 62 contralateral breast cancer 62 elevated LDH 62 tumor resection 62 adjuvant therapies 62 invasive lobular 62 GISTs 62 total thyroidectomy 62 schwannomas 62 chemoradiation 62 infarcts 62 multivariable adjusted 62 colorectal adenoma 62 splenic 62 excisional biopsy 62 VATS lobectomy 62 estrogen receptor negative 62 ductal breast cancer 62 androgen suppression 62 endometrioid 62 invasive ductal 62 squamous 62 ipsilateral 62 HIV HCV coinfected 62 perioperative complications 62 precursor lesions 62 androgen deprivation 62 metachronous 62 urine cytology 62 hypointense 62 localized renal 62 histologically proven 62 prognostic factors 62 tracer uptake 62 invasive carcinomas 62 metastatic lesion 62 endometrial cancers 62 obstructive coronary artery 62 NMIBC 62 osteopenic 62 ipsilateral breast 62 carcinoid tumor 62 chemoradiotherapy 62 cervical carcinoma 62 invasive lobular carcinoma 62 Multivariate analyzes 62 thromboembolic events 62 percutaneous biopsy 62 pathologic examination 62 colorectal liver metastases 62 HGPIN 62 situ LCIS 62 nodular melanoma 62 lobular 62 malignant nodules 62 intraobserver 62 ductal cancer 62 endosonography 62 BRCA mutation carriers 62 arteriography 62 coronary stenosis 62 stage IIIA 62 colorectum 62 elevated CRP 62 treated nonoperatively 62 pulmonary nodules 62 polypoid 62 prognostic variables 62 node dissection 62 retroperitoneal 62 paraganglioma 62 paragangliomas 62 colorectal carcinoma 62 pheochromocytomas 62 metastatic lung cancer 62 comorbidities 62 epithelial ovarian cancer 62 papillary renal cell carcinoma 62 incomplete revascularization 62 TRUS biopsy 62 HER2 overexpression 61 renal artery stenosis 61 untreated metastatic melanoma 61 endoscopic resection 61 ovarian malignancy 61 atypia 61 pathologic diagnosis 61 core needle biopsy 61 perioperative morbidity 61 tumoral 61 neoadjuvant treatment 61 definite stent thrombosis 61 hypoechoic 61 astrocytoma 61 radical cystectomy 61 stage IIIb IV 61 BRCA2 mutation carriers 61 meningiomas 61 biopsy Gleason 61 B7 H3 61 clinically localized prostate 61 unresectable 61 LVNC 61 LV dysfunction 61 intraoperative complications 61 peritumoral 61 peritoneal carcinomatosis 61 locoregional disease 61 mediastinal lymph nodes 61 invasive ductal carcinoma 61 LHRH receptor positive 61 sentinel node biopsy 61 nonischemic 61 visceral metastases 61 benign lesions 61 carcinoids 61 obstructive CAD 61 morphologic 61 subtrochanteric 61 tumor shrinkage 61 revascularization procedures 61 squamous histology 61 hyperplastic 61 supratentorial 61 nephron sparing surgery 61 esophagectomy 61 mesotheliomas 61 metastatic gastric 61 hypervascular 61 CIN2 61 carcinomas 61 hyperintensity 61 MYCN amplification 61 chest radiographs 61 cellularity 61 basal cell carcinoma BCC 61 axillary lymph node dissection 61 progesterone receptor negative 61 recurrent NSCLC 61 ductal carcinomas 61 pelvic lymph nodes 61 ASCUS 61 neoplasia 61 nodular 61 neurologic complications 61 breast carcinomas 61 pulmonary metastases 61 underwent surgical resection 61 pancreatic prostate 61 penetrance 61 hormone receptor status 61 nonmelanoma skin cancers 61 renal dysfunction 61 % CI #.#-#.# [007] 61 chemoembolization 61 carcinoid tumors 61 immunohistochemical staining 61 pathologic fractures 61 hematopoietic cancers 61 atherosclerotic lesions 60 endometrial thickness 60 prospectively defined 60 hypoperfusion 60 HRCT 60 malignant prostate 60 grade gliomas 60 fallopian tube carcinoma 60 biopsy specimen 60 Figure 2C 60 KRAS wild 60 cisplatin chemotherapy 60 lung nodule 60 renal insufficiency 60 taxane therapy 60 surgically resectable 60 neoplastic lesions 60 salpingo oophorectomy 60 thymoma 60 gastroduodenal 60 pelvic ultrasound 60 catheter angiography 60 immunohistochemical 60 axilla 60 postoperative mortality 60 Preoperative 60 genital tract infections 60 Recurrence Score 60 angiographically 60 lung metastasis 60 CR nPR 60 hamartoma 60 anaplastic 60 spontaneous regression 60 transitional cell carcinoma 60 duplex ultrasonography 60 thyroid nodule 60 pericardial effusion 60 multivessel disease 60 intravesical therapy 60 needle aspiration 60 KRAS mutations occur 60 grade squamous intraepithelial 60 cytoreduction 60 cytologic 60 metastatic malignant melanoma 60 multivariable analysis 60 aortic regurgitation 60 CC genotype 60 hemodynamically significant 60 appendiceal 60 clinically insignificant 60 estrogen receptor positive 60 coronary artery stenosis 60 comorbidity 60 carotid artery stenosis 60 metastatic lymph nodes 60 subgroup analyzes 60 recurrent metastatic 60 undetectable PSA 60 parenchymal 60 SLN biopsy 60 malignant lesion 60 malignant lymphoma 60 osteosarcomas 60 thyroglobulin 60 leiomyomas 60 EGFR expression 60 esophageal carcinoma 60 breast cancer subtypes 60 cytologically confirmed 60 gastrectomy 60 invasive coronary angiography 60 debulking surgery 60 Histologic 60 prognostic factor 60 skeletal metastases 60 ductal 60 varices 60 lung carcinomas 60 BRCA mutation 60 prognostic significance 60 clinicopathological features 60 scintigraphy 60 non squamous NSCLC 60 lobectomy 60 graft occlusion 60 adenomas 60 immunoreactivity 60 sleeve lobectomy 60 metastatic tumors 60 aminotransferases 60 recanalization 60 Kaplan Meier analysis 60 cTnT 60 prostate biopsy 60 malignant growths 60 endobronchial 60 multivariate Cox 60 liver resection 60 lumbar disk herniation 60 microscopic hematuria 60 genotypic resistance 60 clinicopathological 60 parathyroid carcinoma 60 troponin T 60 noncalcified 60 adenocarcinoma 60 vertebral fracture 60 gastric cancers 60 extracolonic findings 60 Stent thrombosis 60 HER2 amplification 60 Median survival 60 univariate 60 underwent radical prostatectomy 60 tumor necrosis 60 intracranial hemorrhage ICH 60 Papillary 60 histological 59 left ventricular dysfunction 59 varicoceles 59 Univariate analysis 59 metastatic bladder 59 IV melanoma 59 chest radiograph 59 noncardiac 59 clinico pathological 59 extracapsular 59 surgically resected 59 baseline LDH 59 pleomorphic 59 comorbid conditions 59 lactate dehydrogenase 59 brain metastases 59 infarct size 59 cardiac perfusion 59 carotid plaques 59 #Gy 59 hepatectomy 59 pancreatic carcinoma 59 oophorectomy 59 undergoing CABG 59 cutaneous melanoma 59 paclitaxel eluting stents 59 #F FDG PET 59 colorectal neoplasia 59 urothelial 59 TT genotype 59 IIIA NSCLC 59 pilocytic astrocytoma 59 lobular cancer 59 preoperative 59 distal colon 59 cranial irradiation 59 CK MB 59 Breslow thickness 59 progesterone receptor PR 59 Histopathologic examination 59 elevated ALT 59 thyrotropin levels 59 pituitary adenomas 59 microsatellite instability 59 unresectable tumors 59 histologies 59 femoral neck fracture 59 heavily pretreated patients 59 nonsmall cell lung cancer 59 LV ejection fraction 59 radiographically 59 papillary thyroid carcinoma 59 ejection fractions 59 adenomatous 59 bronchogenic carcinoma 59 T2 weighted images 59 adenocarcinomas 59 intact parathyroid hormone 59 testicular tumors 59 BRCA gene mutation 59 cholangiocarcinoma 59 Adjuvant chemotherapy 59 atypical lobular hyperplasia 59 calcified plaques 59 biliary tract cancer 59 epithelial ovarian 59 EBUS FNA 59 subclinical hypothyroidism 59 bladder cancers 59 dacarbazine DTIC 59 Computed tomography 59 luminal 59 subclinical hyperthyroidism 59 premalignant 59 cTnI 59 carotid plaque 59 ADPKD 59 liposarcoma 59 supraclavicular 59 histopathologic diagnosis 59 white matter hyperintensities 59 neutrophil counts 59 bladder carcinoma 59 malignant lymph nodes 59 hydronephrosis 59 prostate cancer PCa 59 heavily pretreated 59 autonomic dysfunction 59 resections 59 kidney cysts 59 nonmelanoma 59 BRAF V#E mutation 59 KRAS mutation 59 Immunohistochemical staining 59 BRCA1 mutations 59 fine needle aspiration 59 papillary carcinoma 59 submucosal 59 lymphopenia 59 sonographic 59 bilateral oophorectomy 59 preoperative staging 59 surgical debulking 59 pheochromocytoma 59 FOLPI 59 Doppler sonography 59 haematologic 59 Doxil ® 59 Metastases 59 transabdominal 59 transesophageal echocardiography 59 recurrent VTE 59 karyotype 59 transvaginal sonography 59 colectomy 59 renal pelvis 59 axillary 59 colorectal tumors 59 neurofibromas 59 oropharyngeal cancer 59 intima media thickness 59 Rectal cancer 59 extracranial 59 nasopharyngeal carcinoma 59 squamous cell carcinoma SCC 59 prostatic adenocarcinoma 59 hematuria 59 neoplastic 59 medullary thyroid cancer 59 osteochondroma 59 artery stenosis 59 osteoid 59 normal karyotype 59 BRAF mutations 59 polyp recurrence 58 Flu Cy 58 lung adenocarcinomas 58 prior chemotherapy regimens 58 T2DM 58 stratifying patients 58 segmentectomy 58 hepatic resection 58 pathologic 58 recurrent ovarian 58 malignancy 58 nonmalignant 58 small lymphocytic lymphoma 58 hemorrhagic complications 58 Metastatic 58 underwent coronary angiography 58 lower extremity amputation 58 Multivariate analysis 58 Partial Responses 58 bone scintigraphy 58 underarm lymph nodes 58 esophagogastric 58 hip BMD 58 extranodal 58 Asymptomatic 58 seminomas 58 computed tomographic scans 58 CaP 58 orthotopic 58 endoscopic ultrasonography 58 serous ovarian cancer 58 perimenopausal women 58 myocardial ischemia 58 clinicopathologic 58 serum creatinine levels 58 myocardial viability 58 hyperechoic 58 Plain radiographs 58 relapsed MM 58 basal cell cancers 58 colonic polyps 58 aortic insufficiency 58 malignant ovarian 58 HSCT 58 melanoma lesions 58 sonographically guided 58 HBeAg negative 58 chromosomal mutations 58 perfusion defects 58 carotid IMT 58 colorectal gastric 58 cystic lesions 58 precancerous cervical 58 T1 weighted images 58 specific antigen PSA 58 obstructive coronary 58 tricuspid regurgitation 58 BRAF mutation 58 hilar 58 malignant pleural mesothelioma 58 soft tissue sarcomas 58 urothelial cancer 58 abdominal hysterectomy 58 lobular involution 58 chemotherapeutic regimens 58 K ras mutation 58 virologic response 58 serrated polyps 58 thromboembolic 58 mCRC patients 58 MMSE score 58 sentinel lymph nodes 58 subclinical 58 hyperintensities 58 neuroendocrine carcinoma 58 TIMP 58 metastatic renal cell carcinoma 58 undetectable HBV DNA 58 ERBB2 58 MACCE 58 TNF blocker therapy 58 colorectal polyps 58 DLTs 58 cholelithiasis 58 arterial occlusion 58 interobserver agreement 58 postintervention 58 parenchyma 58 colorectal adenocarcinoma 58 evaluable subjects 58 BRCA deficient 58 radical prostatectomy 58 transurethral resection 58 grade cervical intraepithelial 58 Biopsies 58 AML MDS 58 esophageal squamous cell carcinoma 58 NP CRNs 58 lymphocytic 58 prostate adenocarcinoma 58 endometrial hyperplasia 58 astrocytomas 58 complete remissions 58 spinal metastases 58 hypercholesterolemic patients 58 carcinomatosis 58 MR imaging 58 microcalcifications 58 carcinoid 58 complete cytogenetic response 58 differentiated thyroid 58 contralateral 58 multivariate adjustment 58 calculi 58 femoral neck fractures 58 lesions 58 VADT 58 LVEF 58 hypermethylated 58 CCyR 58 fibrinolytic therapy 58 leukopenia 58 breast conserving 58 chest radiography 58 5-fluorouracil/leucovorin 58 undergoing coronary angiography 58 computed tomography scans 58 multicentric 58 surgical excision 58 mL/min/#.# m 2 58 squamous cell histology 58 P = .# 58 minimally symptomatic 58 asymptomatic carotid stenosis 58 histological subtypes 58 mesenteric 58 FDG PET scans 58 platinum refractory 58 paroxysmal AF 58 immunostaining 58 cartilage lesions 58 lesion 58 patients undergoing CABG 58 unfavorable cytogenetics 58 atheroma volume 58 R0 resection 58 arteriolar 58 leucopenia 58 periventricular 58 CTEPH 58 hyperintense lesions 58 intraductal 58 relapsed SCLC 58 CYP#D# genotype 58 lateral radiograph 58 resection 58 cancer mCRC 58 Adenomas 58 NYHA class 58 cervical lymph node 58 RVOT 58 MetS 58 lung resections 58 imatinib therapy 58 cardiac dysfunction 58 pulmonary metastasis 58 acute aortic dissection 58 morphometric vertebral fractures 58 MDCT angiography 58 mutated K ras 58 EGFR mutation 58 #F FDG 58 pretest probability 57 PCNSL 57 computed tomographic scan 57 metaplasia 57 moderate renal impairment 57 MALT lymphoma 57 benign moles 57 mitral regurgitation 57 tumors 57 cytogenic 57 pulmonary infiltrates 57 TKAs 57 thymectomy 57 EBUS 57 RALP 57 lacunar 57 transthoracic 57 intravenous bisphosphonates 57 gastric cardia 57 histologic findings 57 microvascular disease 57 SCr 57 biopsy specimens 57 cisplatin resistant 57 diffuse gastric 57 portal vein thrombosis 57 papillary thyroid cancer 57 benign polyps 57 fibroadenoma 57 follicular lymphomas 57 ruptured aneurysms 57 metastatic prostate cancer 57 Carcinoma 57 hip resurfacing arthroplasty 57 parathyroidectomy 57 prognostic indicator 57 metastatic basal cell 57 penetrating keratoplasty 57 sentinel lymph node 57 colorectal carcinomas 57 GBM tumors 57 ductal lobular 57 Ki# 57 ErbB2 positive 57 reintervention 57 TNF antagonist 57 mRCC 57 ALT flares 57 sirolimus eluting stents 57 evaluable 57 interobserver reliability 57 liver histology 57 peritoneal 57 QRS duration 57 #ng/ml 57 antiretroviral naïve 57 grade dysplasia 57 undergone radical prostatectomy 57 invasive ductal carcinomas 57 laboratory abnormalities 57 dysplastic 57 hepatic metastases 57 echogenic 57 colorectal adenomas 57 PET CT scans 57 ischemic cardiomyopathy 57 cytologic examination 57 KRAS status 57 REYATAZ r arm 57 upper endoscopy 57 underwent radical cystectomy 57 chemoresistant 57 FOLFOX4 57 binary restenosis 57 histologic examination 57 metastatic 57 coronary blockages 57 hormone receptor positive 57 concurrent chemoradiation 57 anemia hemoglobin 57 curable cancers 57 mCRPC 57 sCJD 57 virologic responses 57 osteochondromas 57 bowel resection 57 HBeAg 57 heterotopic ossification 57 perfusion defect 57 invasive ductal breast cancer 57 nucleoside naive patients 57 invasive angiography 57 etiologic 57 tumors GIST 57 metastatic GIST 57 recurrent malignant glioma 57 elevated troponin 57 aortic atherosclerosis 57 gemcitabine Gemzar 57 EpCAM expression 57 partial nephrectomy 57 hypogonadal 57 chemoradiation therapy 57 nonischemic cardiomyopathy 57 BRCA2 carriers 57 distal colon cancer 57 methotrexate therapy 57 androgen ablation 57 nonrandomized 57 situ DCIS 57 gastric atrophy 57 TRUS 57 osteoporotic vertebral compression fractures 57 Colon polyps 57 recurrent glioblastoma multiforme 57 venous thrombosis 57 acetabular dysplasia 57 benign nodules 57 prognostic indicators 57 periprocedural 57 PET CT colonography 57 preoperatively 57 beta blocker therapy 57 proliferative diabetic retinopathy 57 endarterectomy 57 Prognostic factors 57 BRCA mutations 57 virologic failure 57 hsCRP levels 57 helical CT 57 PSA kinetics 57 systolic function 57 esophagogastric junction 57 MR arthrography 57 myocardial infarctions 57 serum aminotransferase levels 57 de novo AML 57 cell carcinomas 57 HER2 positive 57 ALCL 57 refractory ovarian cancer 57 revascularizations 57 PNH patients 57 HBeAg seroconversion 57 RTOG 57 computed tomographic 57 pretransplant 57 resected pancreatic cancer 57 rheumatoid factor 57 hydroxyvitamin D levels 57 repigmentation 57 cytokeratin 57 lymphomas leukemias 57 unfavorable prognostic 57 Retreatment 57 CYPHER Stent 57 urothelial bladder cancer 57 decompensated cirrhosis 57 arthrography 57 thromboembolic complications 57 breast endometrial 57 proliferative retinopathy 57 rectal cancers 57 cerebral angiography 57 chromosomal rearrangement 57 everolimus eluting stents 57 immunohistochemical analysis 57 histological diagnosis 57 heterozygotes 57 premenopausal 57 microvascular complications 57 adverse cytogenetics 57 Stage IIIb 57 troponins 57 subclinical disease 57 neurologic deficits 57 NIHSS 57 uveal melanoma 57 serum ALT 57 Radiographs 57 liver transplant recipients 57 alanine aminotransferase ALT 57 squamous carcinoma 57 overlapping toxicities 57 abdominal adiposity 57 IV malignant melanoma 57 pre cancerous polyps 57 cerebral microbleeds 57 endocrine therapy 57 computerized tomography scan 57 metastatic pancreatic 57 multivariable analyzes 57 leukocytosis 57 familial pancreatic cancer 57 Postoperatively 57 bone metastasis 57 ventricular dysfunction 57 MR spectroscopy 57 varicocele 57 thyroidectomy 57 leiomyoma 57 Alessandro Riva 57 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 57 TURBT 57 multivariate analysis 57 castrate resistant

Back to home page